Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7778 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7628 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.759 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7353 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7283 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7168 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7168 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD2182 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD5951 |
Approved |
0.7012 |
Intermediate Similarity |
NPD37 |
Approved |
0.7 |
Intermediate Similarity |
NPD6858 |
Approved |
0.7 |
Intermediate Similarity |
NPD7094 |
Approved |
0.6988 |
Remote Similarity |
NPD4965 |
Approved |
0.6988 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD4966 |
Approved |
0.6988 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.6972 |
Remote Similarity |
NPD4198 |
Discontinued |
0.697 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.697 |
Remote Similarity |
NPD7819 |
Suspended |
0.6966 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6928 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7228 |
Approved |
0.6918 |
Remote Similarity |
NPD6190 |
Approved |
0.6905 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6901 |
Remote Similarity |
NPD2629 |
Approved |
0.6894 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6882 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6866 |
Remote Similarity |
NPD1238 |
Approved |
0.6866 |
Remote Similarity |
NPD7798 |
Approved |
0.6859 |
Remote Similarity |
NPD3748 |
Approved |
0.6849 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6849 |
Remote Similarity |
NPD5126 |
Approved |
0.6829 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD5408 |
Approved |
0.6815 |
Remote Similarity |
NPD2438 |
Suspended |
0.6815 |
Remote Similarity |
NPD5405 |
Approved |
0.6815 |
Remote Similarity |
NPD5404 |
Approved |
0.6815 |
Remote Similarity |
NPD5406 |
Approved |
0.6802 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6788 |
Remote Similarity |
NPD164 |
Approved |
0.6766 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD7240 |
Approved |
0.6759 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6753 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.675 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6748 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD7411 |
Suspended |
0.6746 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6728 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD5402 |
Approved |
0.6725 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6714 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6706 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6703 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6703 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6688 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6687 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD8319 |
Approved |
0.6667 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6667 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6667 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6646 |
Remote Similarity |
NPD3750 |
Approved |
0.6645 |
Remote Similarity |
NPD7715 |
Approved |
0.6645 |
Remote Similarity |
NPD7714 |
Approved |
0.6645 |
Remote Similarity |
NPD6663 |
Approved |
0.663 |
Remote Similarity |
NPD6535 |
Approved |
0.663 |
Remote Similarity |
NPD6534 |
Approved |
0.6628 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD3226 |
Approved |
0.6627 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6626 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6614 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6609 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6607 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6606 |
Remote Similarity |
NPD5403 |
Approved |
0.6605 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6604 |
Remote Similarity |
NPD2796 |
Approved |
0.6604 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6603 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6601 |
Remote Similarity |
NPD5736 |
Approved |
0.6598 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.6585 |
Remote Similarity |
NPD2533 |
Approved |
0.6585 |
Remote Similarity |
NPD2534 |
Approved |
0.6585 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD5401 |
Approved |
0.6585 |
Remote Similarity |
NPD2532 |
Approved |
0.6573 |
Remote Similarity |
NPD6765 |
Approved |
0.6573 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6573 |
Remote Similarity |
NPD6764 |
Approved |
0.6562 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6562 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6561 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6552 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.655 |
Remote Similarity |
NPD3749 |
Approved |
0.6538 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6528 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6526 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6526 |
Remote Similarity |
NPD7697 |
Approved |
0.6526 |
Remote Similarity |
NPD7698 |
Approved |
0.6524 |
Remote Similarity |
NPD6799 |
Approved |
0.6514 |
Remote Similarity |
NPD7997 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD5667 |
Approved |
0.6497 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6497 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6495 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6495 |
Remote Similarity |
NPD7874 |
Approved |
0.6494 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.649 |
Remote Similarity |
NPD3972 |
Approved |
0.6489 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6483 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6475 |
Remote Similarity |
NPD1930 |
Approved |
0.6475 |
Remote Similarity |
NPD1929 |
Approved |
0.6475 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6474 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6474 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6471 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6465 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6461 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6457 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6456 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6455 |
Remote Similarity |
NPD6776 |
Approved |
0.6455 |
Remote Similarity |
NPD6779 |
Approved |
0.6455 |
Remote Similarity |
NPD6778 |
Approved |
0.6455 |
Remote Similarity |
NPD6782 |
Approved |
0.6455 |
Remote Similarity |
NPD6781 |
Approved |
0.6455 |
Remote Similarity |
NPD6780 |
Approved |
0.6455 |
Remote Similarity |
NPD6777 |
Approved |
0.6453 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.645 |
Remote Similarity |
NPD6873 |
Phase 2 |
0.645 |
Remote Similarity |
NPD6385 |
Approved |
0.645 |
Remote Similarity |
NPD6386 |
Approved |
0.6442 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6442 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6441 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6441 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6441 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6438 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6433 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD5909 |
Discontinued |
0.6429 |
Remote Similarity |
NPD6784 |
Approved |
0.6429 |
Remote Similarity |
NPD6785 |
Approved |
0.6424 |
Remote Similarity |
NPD1281 |
Approved |
0.6416 |
Remote Similarity |
NPD919 |
Approved |
0.6412 |
Remote Similarity |
NPD1934 |
Approved |
0.641 |
Remote Similarity |
NPD7095 |
Approved |
0.6407
|
Remote Similarity |
NPD920 |
Approved |